962 related articles for article (PubMed ID: 32316065)
21. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.
Llitjos JF; Leclerc M; Chochois C; Monsallier JM; Ramakers M; Auvray M; Merouani K
J Thromb Haemost; 2020 Jul; 18(7):1743-1746. PubMed ID: 32320517
[TBL] [Abstract][Full Text] [Related]
22. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
Ornelas-Ricardo D; Jaloma-Cruz AR
Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
[TBL] [Abstract][Full Text] [Related]
23. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic.
Obi AT; Barnes GD; Wakefield TW; Brown S; Eliason JL; Arndt E; Henke PK
J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):526-534. PubMed ID: 32305585
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
[TBL] [Abstract][Full Text] [Related]
26. Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.
Zadow EK; Wundersitz DWT; Hughes DL; Adams MJ; Kingsley MIC; Blacklock HA; Wu SSX; Benson AC; Dutheil F; Gordon BA
Semin Thromb Hemost; 2020 Oct; 46(7):807-814. PubMed ID: 32882720
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 and venous thromboembolism: current insights and prophylactic strategies.
Ambrosino P; Di Minno A; Maniscalco M; Di Minno MND
Ann Med; 2020 Sep; 52(6):239-242. PubMed ID: 32619360
[No Abstract] [Full Text] [Related]
28. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
Aryal MR; Gosain R; Donato A; Pathak R; Bhatt VR; Katel A; Kouides P
Curr Cardiol Rep; 2020 Jun; 22(7):52. PubMed ID: 32529517
[TBL] [Abstract][Full Text] [Related]
29. COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?
Görlinger K; Dirkmann D; Gandhi A; Simioni P
Anesth Analg; 2020 Nov; 131(5):1324-1333. PubMed ID: 33079850
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
[TBL] [Abstract][Full Text] [Related]
31. Severe COVID-19 infection associated with endothelial activation.
Escher R; Breakey N; Lämmle B
Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
[No Abstract] [Full Text] [Related]
32. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
[TBL] [Abstract][Full Text] [Related]
33. The management of venous thromboembolism in hospitalized patients with COVID-19.
Spyropoulos AC
Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
[TBL] [Abstract][Full Text] [Related]
34. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
[No Abstract] [Full Text] [Related]
35. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
[No Abstract] [Full Text] [Related]
36. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
[TBL] [Abstract][Full Text] [Related]
37. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness.
Goldenberg NA; Sochet A; Albisetti M; Biss T; Bonduel M; Jaffray J; MacLaren G; Monagle P; O'Brien S; Raffini L; Revel-Vilk S; Sirachainan N; Williams S; Zia A; Male C;
J Thromb Haemost; 2020 Nov; 18(11):3099-3105. PubMed ID: 33174388
[TBL] [Abstract][Full Text] [Related]
38. Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
Di Micco P; Russo V; Lodigiani C
Medicina (Kaunas); 2020 Sep; 56(10):. PubMed ID: 32992511
[TBL] [Abstract][Full Text] [Related]
39. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 and its implications for thrombosis and anticoagulation.
Connors JM; Levy JH
Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
